De novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 3, 2006, Pages

  Gosmanov, Aidar R ^a   Stentz, Frankie B ^a   Kitabchi, Abbas E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Activated endothelial cells; Diabetes mellitus; Hyperglycemia; Insulin receptor; Insulin resistance

Indexed keywords

CARBON 14; GLUCOSE; GLUCOSE TRANSPORTER 1; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; INTERLEUKIN 8; IODINE 125; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; PROTEIN KINASE B; SLC2A1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

AORTA; ARTICLE; CELL FUNCTION; CYTOKINE PRODUCTION; DRUG BINDING; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INCUBATION TIME; INSULIN RESISTANCE; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; DRUG EFFECT; METABOLISM; WESTERN BLOTTING;

AORTA; BLOTTING, WESTERN; ENDOTHELIAL CELLS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPERGLYCEMIA; INSULIN; INTERLEUKIN-6; INTERLEUKIN-8; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645046936     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00326.2005     Document Type: Article

References (48)

1. Aljada A, Ghanim H, Assian E, and Dandona P. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51: 487-491, 2002.
2. Alpert E, Gruzman A, Totary H, Kaiser N, Reich R, and Sasson S. A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid. Biochem J 362: 413-422, 2002.
3. Bar RS, Boes M, Dake BL, Booth BA, Henley SA, and Sandra A. Insulin, insulin-like growth factors, and vascular endothelium. Am J Med 85: 59-70, 1988.
4. Bar RS, Hoak JC, and Peacock ML. Insulin receptors in human endothelial cells: identification and characterization. J Clin Endocrinol Metab 47: 699-702, 1978.
5. Brandes RP. Role of NADPH oxidases in the control of vascular gene expression. Antioxid Redox Signal 5: 803-811, 2003.
6. Buetler TM, Krauskopf A, and Ruegg UT. Role of superoxide as a signaling molecule. News Physiol Sci 19: 120-123, 2004.
7. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, and Dandona P. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109: 849-854, 2004.
8. Chisalita SI and Arnqvist HJ. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. Am J Physiol Endocrinol Metab 286: E896-E901, 2004.
9. Creager MA, Luscher TF, Cosentino F, and Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108: 1527-1532, 2003.
10. Dandona P, Chaudhuri A, and Aljada A. Endothelial dysfunction and hypertension in diabetes mellitus. Med Clin North Am 88: 911-931, 2004.
11. Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D, Sbraccia P, Spagnoli LG, Sesti G, and Lauro R. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106: 466-472, 2002.
12. Giardino I, Edelstein D, and Brownlee M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97: 1422-1428, 1996.
13. Goldstein BJ, Mahadev K, and Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54: 311-321, 2005.
14. Haffner SJ and Cassells H. Hyperglycemia as a cardiovascular risk factor. Am J Med 115, Suppl 8A: 6S-11S, 2003.
15. Haffner SM. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes. Diabetes Care 22, Suppl 3: C54-C56, 1999.
16. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001.
17. Jialal I, Crettaz M, Hachiya HL, Kahn CR, Moses AC, Buzney SM, and King GL. Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues. Endocrinology 117: 1222-1229, 1985.
18. Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, and King GL. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42: 80-89, 1993.
19. King GL, Buzney SM, Kahn CR, Hetu N, Buchwald S, Macdonald SG, and Rand LI. Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest 71: 974-979, 1983.
20. Kitabchi AE, Challoner DR, and Williams RH. Respiration and lipid peroxidation in tocopherol deficient rat hearts. Proc Soc Exp Biol Med 127: 647-650, 1968.
21. Kitabchi AE, Stentz FB, and Umpierrez GE. Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem Biophys Res Commun 315: 404-407, 2004.
22. Kondo T and Kahn CR. Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 279: 37997-38006, 2004.
23. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, and Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115: 2277-2286, 2005.
24. Li G, Barrett EJ, Wang H, Chai W, and Liu Z. Insulin at physiological concentrations selectively activates insulin but not IGF-1 or insulin/IGF-1 hybrid receptors in endothelial cells. Endocrinology 146: 4690-4696, 2005.
25. Li L, Sawamura T, and Renier G. Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes 52: 1843-1850, 2003.
26. Mahadev K, Wu X, Motoshima H, and Goldstein BJ. Integration of multiple downstream signals determines the net effect of insulin on MAP kinase vs. PI 3′-kinase activation: potential role of insulin-stimulated H(2)O(2). Cell Signal 16: 323-331, 2004.
27. Mann GE, Yudilevich DL, and Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83: 183-252, 2003.
28. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, and Dandona P. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75: 767-772, 2002.
29. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, and Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85: 2970-2973, 2000.
30. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
31. Pekala P, Marlow M, Heuvelman D, and Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 265: 18051-18054, 1990.
32. Salt IP, Morrow VA, Brandie FM, Connell JM, and Petrie JR. High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser1177 phosphorylation in human aortic endothelial cells. J Biol Chem 278: 18791-18797, 2003.
33. Schnyder B, Pittet M, Durand J, and Schnyder-Candrian S. Rapid effects of glucose on the insulin signaling of endothelial NO generation and epithelial Na transport. Am J Physiol Endocrinol Metab 282: E87-E94, 2002.
34. Sheetz MJ and King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588, 2002.
35. Srinivasan S, Hatley ME, Reilly KB, Danziger EC, and Hedrick CC. Modulation of PPARalpha expression and inflammatory interleukin-6 production by chronic glucose increases monocyte/endothelial adhesion. Arterioscler Thromb Vasc Biol 24: 851-857, 2004.
36. Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, and Hedrick CC. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res 92: 371-377, 2003.
37. Stentz FB and Kitabchi AE. Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun 335: 491-495, 2005.
38. Stentz FB, Umpierrez GE, Cuervo R, and Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53: 2079-2086, 2004.
39. Stentz FB, Zamber CN, and Kitabchi AE. Transcriptome and proteome expression in activated CD4 and CD8 T lymphocytes and muscle in normal and type 2 diabetes. Ann Meet Endocrinol Assoc New Orleans, LA, 2004, p. OR8-5.
40. Stern M. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance. Diabetes Care 22, Suppl 3: C2-C5, 1999.
41. Temaru R, Urakaze M, Satou A, Yamazaki K, Nakamura N, and Kobayashi M. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia 40: 610-613, 1997.
42. Tesfamariam B, Brown ML, and Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87: 1643-1648, 1991.
43. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development, and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
44. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, and Dandona P. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52: 2882-2887, 2003.
45. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment, and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
46. Wei M, Gaskill SP, Haffner SM, and Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21: 1167-1172, 1998.
47. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, and Creager MA. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97: 1695-1701, 1998.
48. Zeng G and Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98: 894-898, 1996.